Yinghui Guan
Associate Director Clinical Biomarker @Arcus Biosciences
Signup · Get unlimited contacts
WORK HISTORY
Associate Director Clinical Biomarker @Arcus Biosciences
US
Clinical biomarker strategy for Ph1-2 clinical-stage programsIntegrating multi-omic and serum proteitn data and deep scientific insights in oncology to reveal MoA of HIF-2a inhibitor casdatifan and anti-TIGIT domvanalimumabReverse translation to identify new PD biomarkers related to HIF-2a dependency and casdatifan efficacy- Design and adapt new biomarker strategy for evolving combination partners of casdatifan- Disease areas of focus: RCC and gastric cancer- Lead cross-function effort for integrated biomarker analyses- Author regulatory documents, e.g. protocol amendments, IB, etc.
EDUCATION
Peking University
B.S., Ecology and Environmental Biology
Peking University
MS, Biochemistry and Molecular Biology
The University of British Columbia
PhD, Malignant Stem Cells in Acute Myeloid Leukemia
SKILLS
ABOUT YINGHUI GUAN
Passionate cancer biologist and clinical biomarker lead with deep knowledge in tumor intrinsic and microenvironment biology and extensive experience in cancer genomics and clinical biomarker development/translational medicine in both in top-tier biopharma and innovative biotech firms; High levels of resourcefulness, excellent communication and presentation skills; A collaborative and resourceful team player
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.